High-Purity Phospholipids
AssigneeVascular Biogenics Ltd.
InventorsGideon HALPERIN, Eti KOVALEVSKI-ISHAI
Life of this patent
Estimating the term…
Abstract
Novel synthetic routes, which are highly applicable for industrial preparation of therapeutically beneficial oxidized phospholipids, are disclosed. Particularly, novel methods for efficiently preparing compounds having a glycerolic backbone and one or more oxidized moieties attached to the glycerolic backbone, which are devoid of column chromatography are disclosed. Further disclosed are novel methods of introducing phosphorus-containing moieties such as phosphate moieties to compounds having glycerolic backbone and intermediates formed thereby. Further disclosed is substantially pure 1-hexadecyl-2-(4′-carboxy)butyl-sn-glycero-3-phosphocholine (CI-201).
Claims19
1-20. (canceled)
A method of suppressing atherogenesis comprising administering to a subject in need of treatment a therapeutically effective amount of substantially pure 1-hexadecyl-2-(4′-carboxy)butyl-sn-glycero-3-phosphocholine.
An oral pharmaceutical composition comprising a therapeutically effective amount of substantially pure 1-hexadecyl-2-(4′-carboxy)butyl-sn-glycero-3-phosphocholine and a pharmaceutically acceptable carrier, wherein the pharmaceutical composition is a capsule.
Dependencies are inferred from the claim text.